Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (6): 496-503.doi: 10.35541/cjd.20220791
• Original Articles • Previous Articles Next Articles
Chen Qiquan, Kong Minmin, Yang Xianjie, Wang Huan, Li Jian, Zhang Mingwang, Song Zhiqiang
Received:
2022-11-09
Revised:
2023-02-01
Online:
2023-06-15
Published:
2023-06-05
Contact:
Song Zhiqiang
E-mail:drsongzq@hotmail.com
Supported by:
Chen Qiquan, Kong Minmin, Yang Xianjie, Wang Huan, Li Jian, Zhang Mingwang, Song Zhiqiang. Clinical analysis of allergen reactivity and atopic disease history in 168 patients with chronic inducible urticaria[J]. Chinese Journal of Dermatology, 2023, 56(6): 496-503.doi:10.35541/cjd.20220791
[1] | Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria[J]. Allergy, 2022,77(3):734⁃766. doi: 10.1111/all.15090. |
[2] | Pozderac I, Lugović⁃Mihić L, Artuković M, et al. Chronic inducible urticaria: classification and prominent features of physical and non⁃physical types[J]. Acta Dermatovenerol Alp Pannonica Adriat, 2020,29(3):141⁃148. doi: 10.15570/actaapa. 2020.29. |
[3] | Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence[J]. J Allergy Clin Immunol, 2018,141(2):638⁃649. doi: 10.1016/j.jaci.2017.06.032. |
[4] | 中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南(2022版)[J]. 中华皮肤科杂志, 2022,55(12):1041⁃1049. doi: 10.35541/cjd.20220609. |
[5] | Heinzerling L, Mari A, Bergmann KC, et al. The skin prick test ⁃ European standards[J]. Clin Transl Allergy, 2013,3(1):3. doi: 10.1186/2045⁃7022⁃3⁃3. |
[6] | Qian T, Li S, Chen Q, et al. Efficacy and safety of ebastine dose escalation in chronic urticaria: a prospective study[J]. Dermatol Ther, 2022,35(5):e15386. doi: 10.1111/dth.15386. |
[7] | Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias⁃The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision[J]. Allergy, 2016,71(6):780⁃802. doi: 10.1111/all.12884. |
[8] | Zhong H, Song Z, Chen W, et al. Chronic urticaria in Chinese population: a hospital⁃based multicenter epidemiological study[J]. Allergy, 2014,69(3):359⁃364. doi: 10.1111/all.12338. |
[9] | Fukunaga A, Washio K, Hatakeyama M, et al. Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management[J]. Clin Auton Res, 2018,28(1):103⁃113. doi: 10.1007/s10286⁃017⁃0418⁃6. |
[10] | Pezzolo E, Peroni A, Gisondi P, et al. Heat urticaria: a revision of published cases with an update on classification and management[J]. Br J Dermatol, 2016,175(3):473⁃478. doi: 10. 1111/bjd.14543. |
[11] | Maltseva N, Borzova E, Fomina D, et al. Cold urticaria ⁃ what we know and what we do not know[J]. Allergy, 2021,76(4):1077⁃1094. doi: 10.1111/all.14674. |
[12] | Schoepke N, Młynek A, Weller K, et al. Symptomatic dermographism: an inadequately described disease[J]. J Eur Acad Dermatol Venereol, 2015,29(4):708⁃712. doi: 10.1111/jdv.12661. |
[13] | Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticaria[J]. Allergy, 2009,64(9):1256⁃1268. doi: 10.1111/j. 1398⁃9995.2009.02132.x. |
[14] | Chen QQ, Zhong H, Shong ZQ, et al. Cold contact urticaria combined with cold⁃dependent dermographism and serum autoreactivity: what have we ignored?[J]. Int J Dermatol Venereol, 2019,2(1):43⁃44. doi:10.3760/cma.j.issn.2096⁃5540.2019.01. 010. |
[15] | Fukunaga A, Bito T, Tsuru K, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes[J]. J Allergy Clin Immunol, 2005,116(2):397⁃402. doi: 10.1016/j.jaci.2005.05.024. |
[16] | Fukunaga A, Oda Y, Imamura S, et al. Cholinergic urticaria: subtype classification and clinical approach[J]. Am J Clin Dermatol, 2023,24(1):41⁃54. doi: 10.1007/s40257⁃022⁃00728⁃6. |
[17] | Dressler C, Werner RN, Eisert L, et al. Chronic inducible urticaria: a systematic review of treatment options[J]. J Allergy Clin Immunol, 2018,141(5):1726⁃1734. doi: 10.1016/j.jaci.2018.01.031. |
[18] | Kirchhof MG, de Gannes GC. Atopy associated with positive patch test and possible allergic contact dermatitis[J]. J Cutan Med Surg, 2018,22(4):405⁃410. doi: 10.1177/1203475418758988. |
[19] | Karakaya G, Ozturk AB, Kalyoncu AF. Prediction of atopy by skin prick tests in patients with asthma and/or persistent rhinitis[J]. Allergol Immunopathol (Madr), 2012,40(1):37⁃40. doi: 10.1016/j.aller.2011.01.005. |
[20] | Garcia⁃Marcos L, Sanchez⁃Solis M, Martinez⁃Torres AE, et al. Phadiatop compared to skin⁃prick test as a tool for diagnosing atopy in epidemiological studies in schoolchildren[J]. Pediatr Allergy Immunol, 2007,18(3):240⁃244. doi: 10.1111/j.1399⁃3038.2006.00508.x. |
[21] | Kulthanan K, Wachirakaphan C. Prevalence and clinical characteristics of chronic urticaria and positive skin prick testing to mites[J]. Acta Derm Venereol, 2008,88(6):584⁃588. doi: 10.2340/00015555⁃0546. |
[22] | Shalom G, Magen E, Dreiher J, et al. Chronic urticaria and atopic disorders: a cross⁃sectional study of 11 271 patients[J]. Br J Dermatol, 2017,177(4):e96⁃e97. doi: 10.1111/bjd.15347. |
[23] | Altrichter S, Koch K, Church MK, et al. Atopic predisposition in cholinergic urticaria patients and its implications[J]. J Eur Acad Dermatol Venereol, 2016,30(12):2060⁃2065. doi: 10.1111/jdv. 13765. |
[24] | Kulthanan K, Ungprasert P, Tuchinda P, et al. Symptomatic dermographism: a systematic review of treatment options[J]. J Allergy Clin Immunol Pract, 2020,8(9):3141⁃3161. doi: 10.1016/j.jaip.2020.05.016. |
[25] | Maurer M, Schütz A, Weller K, et al. Omalizumab is effective in symptomatic dermographism⁃results of a randomized placebo⁃controlled trial[J]. J Allergy Clin Immunol, 2017,140(3):870⁃873.e5. doi: 10.1016/j.jaci.2017.01.042. |
[26] | Giménez⁃Arnau AM, Ribas⁃Llauradó C, Mohammad⁃Porras N, et al. IgE and high⁃affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance[J]. Clin Transl Allergy, 2022,12(2):e12117. doi: 10.1002/clt2.12117. |
[27] | Metz M, Schütz A, Weller K, et al. Omalizumab is effective in cold urticaria⁃results of a randomized placebo⁃controlled trial[J]. J Allergy Clin Immunol, 2017,140(3):864⁃867.e5. doi: 10.1016/j.jaci.2017.01.043. |
[28] | Kozel MM, Mekkes JR, Bossuyt PM, et al. Natural course of physical and chronic urticaria and angioedema in 220 patients[J]. J Am Acad Dermatol, 2001,45(3):387⁃391. doi: 10.1067/mjd.2001.116217. |
[29] | Bal F, Kahveci M, Soyer O, et al. Chronic inducible urticaria subtypes in children: clinical features and prognosis[J]. Pediatr Allergy Immunol, 2021,32(1):146⁃152. doi: 10.1111/pai.13324. |
[30] | Abajian M, Młynek A, Maurer M. Physical urticaria[J]. Curr Allergy Asthma Rep, 2012,12(4):281⁃287. doi: 10.1007/s11882⁃012⁃0269⁃0. |
[31] | Fleischer M, Grabbe J. Physical urticaria[J]. Hautarzt, 2004,55(4):344⁃349. doi: 10.1007/s00105⁃004⁃0691⁃x. |
[32] | Zuberbier T, Maurer M. Urticaria: current opinions about etiology, diagnosis and therapy[J]. Acta Derm Venereol, 2007,87(3):196⁃205. doi: 10.2340/00015555⁃0240. |
[33] | Möller A, Henning M, Zuberbier T, et al. Epidemiology and clinical aspects of cold urticaria[J]. Hautarzt, 1996,47(7):510⁃514. doi: 10.1007/s001050050461. |
[34] | Wanderer AA, Grandel KE, Wasserman SI, et al. Clinical characteristics of cold⁃induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria[J]. J Allergy Clin Immunol, 1986,78(3 Pt 1):417⁃423. doi: 10.1016/0091⁃6749(86)90027⁃8. |
[35] | Kim JE, Eun YS, Park YM, et al. Clinical characteristics of cholinergic urticaria in Korea[J]. Ann Dermatol, 2014,26(2):189⁃194. doi: 10.5021/ad.2014.26.2.189. |
[36] | Moore⁃Robinson M, Warin RP. Some clinical aspects of cholinergic urticaria[J]. Br J Dermatol, 1968,80(12):794⁃799. doi: 10.1111/j.1365⁃2133.1968.tb11948.x. |
[1] | Jiao Qingqing, Zhang Xiaoyan, Ji Jiang. Biological indicators related to disease activity of chronic spontaneous urticaria: an update [J]. Chinese Journal of Dermatology, 2023, 56(6): 559-562. |
[2] | Chen Qiquan, Yang Xianjie, Wang Wenwen, Liang Gaopeng, Song Zhiqiang . Development and application of clinical assessment tools for cholinergic urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 563-566. |
[3] | Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023)” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539. |
[4] | Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023) [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488. |
[5] | Chinese Society of Dermatology, China Dermatologist Association. Expert consensus on treat-to-target in chronic spontaneous urticaria (2023) [J]. Chinese Journal of Dermatology, 2023, 56(6): 489-495. |
[6] | Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558. |
[7] | Zhang Liming, Xiao Ting. Update of the autoimmune pathogenesis of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(6): 567-570. |
[8] | Yang Nali, Xu Qiuyang, Wu Hanwen, Ye Yahui, Zhu Jiling, Liu Jingjing, Li Zhiming. Efficacy and safety of omalizumab in the treatment of chronic urticaria: a retrospective analysis [J]. Chinese Journal of Dermatology, 2023, 56(6): 518-524. |
[9] | Su Chang, Sui Xiuli, Liu Ruiling, Cao Yiqun, Jiang Hong, Yan Cairong, Wang Huiping, Qi Yuqing. Omalizumab for the treatment of 74 patients with chronic spontaneous urticaria accompanied by other allergic diseases: a clinical analysis [J]. Chinese Journal of Dermatology, 2023, 56(6): 512-517. |
[10] | Wang Xin, Liu Lijuan, Li Linfeng. Clinical features of chronic spontaneous urticaria in China: results from a hospital-based multicenter epidemiological survey [J]. Chinese Journal of Dermatology, 2023, 56(6): 525-530. |
[11] | Li Liqiao, Peng Cong, Chen Xiang, Li Jie. Efficacy of omalizumab in the treatment of chronic urticaria patients with poor response to antihistamines: a single-center retrospective study [J]. Chinese Journal of Dermatology, 2023, 56(6): 504-511. |
[12] | Yang Xiaojing, Chen Leigang, Wang Shining, Wu Yuanhui, Zhu Youjin, An Guozhi, Zhou Xiangzhao, Meng Zhaoying. Correlation of serum interleukin-9 and platelet-activating factor levels with total IgE levels, disease severity and disease course in patients with chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(4): 337-341. |
[13] | Yu Miao, Song Xiaoting, Liu Bo, Liao Shuanglu, Luan Tingting, Zhao Zuotao. Autologous serum skin test: immunological mechanisms and its associations with clinical features and prognosis of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(2): 184-187. |
[14] | . Correlation between food-specific IgG antibodies and phenotypes of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(2): 130-135. |
[15] | Zhao Ying, Zhang Xiaoyan, Chen Lu, Su Yuhua, Ding Yujie, Leng Hong, Ji Jiang. Predictive factors for the efficacy of omalizumab in the treatment of refractory chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(1): 22-28. |
|